220 related articles for article (PubMed ID: 22341881)
1. Metabolic manifestations of polycystic ovary syndrome in nonobese adolescents: retinol-binding protein 4 and ectopic fat deposition.
Sopher AB; Gerken AT; Blaner WS; Root JM; McMahon DJ; Oberfield SE
Fertil Steril; 2012 Apr; 97(4):1009-15. PubMed ID: 22341881
[TBL] [Abstract][Full Text] [Related]
2. Serum retinol-binding protein 4 levels in nonobese women with polycystic ovary syndrome.
Chan TF; Tsai YC; Chiu PR; Chen YL; Lee CH; Tsai EM
Fertil Steril; 2010 Feb; 93(3):869-73. PubMed ID: 19028383
[TBL] [Abstract][Full Text] [Related]
3. Retinol-binding protein 4 is associated with insulin resistance, but appears unsuited for metabolic screening in women with polycystic ovary syndrome.
Möhlig M; Weickert MO; Ghadamgahi E; Arafat AM; Spranger J; Pfeiffer AF; Schöfl C
Eur J Endocrinol; 2008 Apr; 158(4):517-23. PubMed ID: 18362299
[TBL] [Abstract][Full Text] [Related]
4. Retinol-binding protein 4 levels are elevated in polycystic ovary syndrome women with obesity and impaired glucose metabolism.
Hahn S; Backhaus M; Broecker-Preuss M; Tan S; Dietz T; Kimmig R; Schmidt M; Mann K; Janssen OE
Eur J Endocrinol; 2007 Aug; 157(2):201-7. PubMed ID: 17656599
[TBL] [Abstract][Full Text] [Related]
5. Retinol-binding protein 4 and insulin resistance in polycystic ovary syndrome.
Hutchison SK; Harrison C; Stepto N; Meyer C; Teede HJ
Diabetes Care; 2008 Jul; 31(7):1427-32. PubMed ID: 18390799
[TBL] [Abstract][Full Text] [Related]
6. Are plasma levels of visfatin and retinol-binding protein 4 (RBP4) associated with body mass, metabolic and hormonal disturbances in women with polycystic ovary syndrome?
Olszanecka-Glinianowicz M; Madej P; Zdun D; Bożentowicz-Wikarek M; Sikora J; Chudek J; Skałba P
Eur J Obstet Gynecol Reprod Biol; 2012 May; 162(1):55-61. PubMed ID: 22397743
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of retinol-binding protein 4 and adiponectin in women with polycystic ovary syndrome: associations with visceral fat but no evidence for fat mass-independent effects on pathogenesis in this condition.
Barber TM; Hazell M; Christodoulides C; Golding SJ; Alvey C; Burling K; Vidal-Puig A; Groome NP; Wass JA; Franks S; McCarthy MI
J Clin Endocrinol Metab; 2008 Jul; 93(7):2859-65. PubMed ID: 18445670
[TBL] [Abstract][Full Text] [Related]
8. Retinol-binding protein 4 correlates with triglycerides but not insulin resistance in prepubertal children with and without premature adrenarche.
Sopher AB; Gerken AT; Lee EJ; Blaner WE; Deeds S; Gallagher D; Shungu DC; Mao X; Hassoun A; Mahon DJ; Oberfield SE
J Pediatr Endocrinol Metab; 2011; 24(9-10):683-7. PubMed ID: 22145457
[TBL] [Abstract][Full Text] [Related]
9. Serum retinol-binding protein 4, leptin, and plasma asymmetric dimethylarginine levels in obese and nonobese young women with polycystic ovary syndrome.
Yildizhan R; Ilhan GA; Yildizhan B; Kolusari A; Adali E; Bugdayci G
Fertil Steril; 2011 Jul; 96(1):246-50. PubMed ID: 21600576
[TBL] [Abstract][Full Text] [Related]
10. The relationship between retinol-binding protein 4 levels, insulin resistance, androgen hormones and polycystic ovary syndrome.
Mellati AA; Sharifi F; Sajadinejad M; Sohrabi D; Mazloomzadeh S
Scand J Clin Lab Invest; 2012 Feb; 72(1):39-44. PubMed ID: 22023042
[TBL] [Abstract][Full Text] [Related]
11. Retinol-binding protein 4, as a negative acute-phase reactant in polycystic ovary syndrome.
Güdücü N; Görmüş U; Telatar B; Dünde I
Minerva Endocrinol; 2014 Dec; 39(4):299-304. PubMed ID: 25371056
[TBL] [Abstract][Full Text] [Related]
12. Elevated serum RBP4 is associated with insulin resistance in women with polycystic ovary syndrome.
Weiping L; Qingfeng C; Shikun M; Xiurong L; Hua Q; Xiaoshu B; Suhua Z; Qifu L
Endocrine; 2006 Dec; 30(3):283-7. PubMed ID: 17526940
[TBL] [Abstract][Full Text] [Related]
13. Kisspeptin, leptin, and retinol-binding protein 4 in women with polycystic ovary syndrome.
Jeon YE; Lee KE; Jung JA; Yim SY; Kim H; Seo SK; Cho S; Choi YS; Lee BS
Gynecol Obstet Invest; 2013; 75(4):268-74. PubMed ID: 23571154
[TBL] [Abstract][Full Text] [Related]
14. Early endocrine, metabolic, and sonographic characteristics of polycystic ovary syndrome (PCOS): comparison between nonobese and obese adolescents.
Silfen ME; Denburg MR; Manibo AM; Lobo RA; Jaffe R; Ferin M; Levine LS; Oberfield SE
J Clin Endocrinol Metab; 2003 Oct; 88(10):4682-8. PubMed ID: 14557441
[TBL] [Abstract][Full Text] [Related]
15. Low free plasma levels of retinol-binding protein 4 in insulin-resistant subjects with polycystic ovary syndrome.
Diamanti-Kandarakis E; Livadas S; Kandarakis SA; Papassotiriou I; Margeli A
J Endocrinol Invest; 2008 Nov; 31(11):950-5. PubMed ID: 19169049
[TBL] [Abstract][Full Text] [Related]
16. Cross-sectional analysis of the effects of age on the hormonal, metabolic, and ultrasonographic features and the prevalence of the different phenotypes of polycystic ovary syndrome.
Panidis D; Tziomalos K; Macut D; Delkos D; Betsas G; Misichronis G; Katsikis I
Fertil Steril; 2012 Feb; 97(2):494-500. PubMed ID: 22192350
[TBL] [Abstract][Full Text] [Related]
17. Raised serum, adipocyte, and adipose tissue retinol-binding protein 4 in overweight women with polycystic ovary syndrome: effects of gonadal and adrenal steroids.
Tan BK; Chen J; Lehnert H; Kennedy R; Randeva HS
J Clin Endocrinol Metab; 2007 Jul; 92(7):2764-72. PubMed ID: 17456573
[TBL] [Abstract][Full Text] [Related]
18. Dietary glycemic index is associated with less favorable anthropometric and metabolic profiles in polycystic ovary syndrome women with different phenotypes.
Graff SK; Mário FM; Alves BC; Spritzer PM
Fertil Steril; 2013 Oct; 100(4):1081-8. PubMed ID: 23830153
[TBL] [Abstract][Full Text] [Related]
19. Serum RBP4 positively correlates with triglyceride level but not with BMI, fat mass and insulin resistance in healthy obese and non-obese individuals.
Korek E; Gibas-Dorna M; Chęcińska-Maciejewska Z; Krauss H; Łagiedo-Żelazowska M; Kołodziejczak B; Bogdański P
Biomarkers; 2018 Nov; 23(7):683-688. PubMed ID: 29786448
[TBL] [Abstract][Full Text] [Related]
20. Relation of intra-abdominal fat distribution to metabolic disorders in nonobese patients with polycystic ovary syndrome.
Yildirim B; Sabir N; Kaleli B
Fertil Steril; 2003 Jun; 79(6):1358-64. PubMed ID: 12798883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
